Velocity Clinical Research

East Syracuse, New York 13057

1 studies enrolling now · 6 studies all time

What they study most

Alzheimer Disease, Alzheimers Disease, Cognitive Dysfunction, Dementia, Diabetic Retinopathy, Epstein-Barr Virus Infection, Non-Alcoholic Fatty Liver Disease

Studies at this site

• [18F]PI-2620 Phase 3 Histopathological Study — Recruiting now
• A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE) — Running, not enrolling
• A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults — Running, not enrolling
• A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease — Stopped early
• A Study to Evaluate the Efficacy and Safety of Gantenerumab in Participants at Risk for or at the Earliest Stages of Alzheimer's Disease (AD) — Stopped early
• A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy — Completed